17-N-Allylamino-17-demethoxygeldanamycin: Cancer, Leukemia, Tumor, Hsp90, Clinical trial, Pharmaceutical drug, Antineoplastic

Prices from
127.10

Sponsored links

COMPARE ALL WEBSHOPS (1)

Description

17-N-Allylamino-17-demethoxygeldanamycin: Cancer, Leukemia, Tumor, Hsp90, Clinical trial, Pharmaceutical drug, Antineoplastic

Description Description
Product Specifications Product specifications
Related results Related results
Next
Previous

Compare webshops (1)

Sponsored links · Some shops pay us a fee

Sort by:

€ 127.10

Description (0)

17-N-Allylamino-17-demethoxygeldanamycin: Cancer, Leukemia, Tumor, Hsp90, Clinical trial, Pharmaceutical drug, Antineoplastic

Product specifications

Brand OmniScriptum
EAN
  • 9786132919274

OmniScriptum

Clinical Trial Protocol: trial, Pharmaceutical drug, Biotechnology, Medical device

€ 127.10
More Information More Info

OmniScriptum

Cancer and leukemia Group B: cancer, Leukemia, Lymphoma, Breast Lung Melanoma, Clinical trial, Acute

€ 168.22
More Information More Info

OmniScriptum

Approved Drug: Food and Drug Administration, Pharmaceutical drug, New Application, Clinical trial, discovery

€ 127.10
More Information More Info

OmniScriptum

Field Experiment: Experiment, Laboratory, Clinical trial, Pharmaceutical drug, Discrimination, Health care

€ 127.10
More Information More Info
Featured Choice
€ 127.10
To Shop